Crispr Therapeutics Ag · NASDAQ:CRSP

Patel Naimish sold 3,786 Crispr Therapeutics Ag shares (Form 4)

Traded May 28 to May 29, 2026 · Filed Jun 1, 2026

From May 28 to May 29, 2026, Patel Naimish (Chief Medical Officer) sold 3,786 Crispr Therapeutics Ag shares at US$55.62 for US$211K, leaving 19,357 shares. Filed Jun 1, 2026 (Form 4).

Sold
3,786 shares
Price
US$55.62
Value
US$211K
Holding after
19,357 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 28, 2026Common SharesOption exercise10,00023,143Direct
May 29, 2026Common SharesSale3,786US$55.6219,357Direct

Source

View original at SEC

Related